Success Metrics

Clinical Success Rate
94.0%

Based on 47 completed trials

Completion Rate
94%(47/50)
Active Trials
2(3%)
Results Posted
17%(8 trials)
Terminated
3(5%)

Phase Distribution

Ph phase_1
6
10%
Ph phase_2
9
14%
Ph not_applicable
1
2%

Phase Distribution

6

Early Stage

9

Mid Stage

0

Late Stage

Phase Distribution16 total trials
Phase 1Safety & dosage
6(37.5%)
Phase 2Efficacy & side effects
9(56.3%)
N/ANon-phased studies
1(6.3%)

Highest Phase Reached

Phase 2

Trial Status & Enrollment

Completion Rate

88.7%

47 of 53 finished

Non-Completion Rate

11.3%

6 ended early

Currently Active

2

trials recruiting

Total Trials

63

all time

Status Distribution
Active(2)
Completed(47)
Terminated(6)
Other(8)

Detailed Status

Completed47
unknown8
Withdrawn3
Terminated3
Active, not recruiting2

Development Timeline

Analytics

Development Status

Total Trials
63
Active
2
Success Rate
94.0%
Most Advanced
Phase 2

Trials by Phase

Phase 16 (37.5%)
Phase 29 (56.3%)
N/A1 (6.3%)

Trials by Status

unknown813%
withdrawn35%
completed4775%
terminated35%
active_not_recruiting23%

Recent Activity

2 active trials
Showing 5 of 63
active_not_recruiting

Infection Prophylaxis and Management in Treating Cytomegalovirus (CMV) Infection in Patients With Hematologic Malignancies Previously Treated With Donor Stem Cell Transplant

NCT01199562
active_not_recruitingphase_1

Genetic Testing in Predicting Biomarkers of Recurrence in Patients With Prostate Cancer Undergoing Surgery

NCT00977457
completedphase_1

Ursodiol, Combination Chemotherapy, and Bevacizumab in Treating Patients With Stage IV Colorectal Cancer

NCT00873275
completedphase_2

Combination Chemotherapy and Pralatrexate as First-Line Therapy in Treating Patients With Non-Hodgkin Lymphoma

NCT01336933
completedphase_2

Bortezomib and Rituximab in Treating Patients With Mantle Cell Lymphoma Who Have Previously Undergone Stem Cell Transplantation

NCT01267812
View all 63 trials

Clinical Trials (63)

Showing 20 of 63 trialsScroll for more
NCT01199562

Infection Prophylaxis and Management in Treating Cytomegalovirus (CMV) Infection in Patients With Hematologic Malignancies Previously Treated With Donor Stem Cell Transplant

Active Not Recruiting
NCT00977457Phase 1

Genetic Testing in Predicting Biomarkers of Recurrence in Patients With Prostate Cancer Undergoing Surgery

Active Not Recruiting
NCT00873275Phase 1

Ursodiol, Combination Chemotherapy, and Bevacizumab in Treating Patients With Stage IV Colorectal Cancer

Completed
NCT01336933Phase 2

Combination Chemotherapy and Pralatrexate as First-Line Therapy in Treating Patients With Non-Hodgkin Lymphoma

Completed
NCT01267812Phase 2

Bortezomib and Rituximab in Treating Patients With Mantle Cell Lymphoma Who Have Previously Undergone Stem Cell Transplantation

Completed
NCT01567722

Collecting and Studying Tissue Samples From Patients With HIV-Associated Malignancies

Terminated
NCT01160705

Biomarkers of Response to Taxotere in HRPC. ICORG 08-08, V2

Completed
NCT01319526

Biomarkers in Blood Samples From Patients With HIV Infection and Stage III or Stage IV Hodgkin Lymphoma Undergoing Chemotherapy

Terminated
NCT01383668Phase 1

Sirolimus and Gold Sodium Thiomalate in Treating Patients With Advanced Squamous Non-Small Cell Lung Cancer

Withdrawn
NCT01476410Phase 2

Brentuximab Vedotin and Combination Chemotherapy in Treating Older Patients With Previously Untreated Stage II-IV Hodgkin Lymphoma

Unknown
NCT01563861

S9704-S0014-S0313A Studying Genes in Samples From Patients With Limited or Advanced Diffuse Large B-Cell Lymphoma

Completed
NCT02984059

Study Assessing Risk Factors for Abdominal Pain in Children With Inflammatory Bowel Disease

Completed
NCT01270880Phase 2

Hsp90 Inhibitor STA-9090 in Treating Patients With Metastatic Hormone-Resistant Prostate Cancer Previously Treated With Docetaxel-Based Chemotherapy

Completed
NCT00821964Phase 2

Topical Imiquimod and Abraxane in Treating Patients With Advanced Breast Cancer

Completed
NCT00466752Phase 2

Sorafenib Tosylate and Gene Expression Analysis in Patients Undergoing Surgery For High-Risk Localized Prostate Cancer

Completed
NCT01105312Phase 1

Panobinostat and Letrozole in Treating Patients With Metastatic Breast Cancer

Completed
NCT01414595

Study of Tissue Samples From Patients With Non-Small Cell Lung Cancer

Completed
NCT00897845

Studying Tumor Samples From Women Who Have Undergone Chemotherapy for Breast Cancer

Completed
NCT01505699

Biomarkers in Samples From Patients With B-Cell Acute Lymphoblastic Leukemia

Completed
NCT01421875

Biomarker Study of Chemotherapy Resistance and Outcomes in Samples From Older Patients With Acute Myeloid Leukemia

Completed

Drug Details

Intervention Type
GENETIC
Total Trials
63